- HK$52.02bn
- HK$171.29bn
- CNY575.17bn
Brief: Sinopharm Group Posts FY Profit RMB10.42 Billion
Brief: Sinopharm Group To Appoint Sun Jinglin As An Executive Director
Brief: Citigroup's Long Position In H-Shares Of Sinopharm Group Decreases To 4.86% - HKEX
Brief: Sinopharm Group Posts 9-Mths Total Operating Revenue Of RMB442.42 Bln
Brief: Sinopharm Group Posts Qtrly Net Profit Attributable For Sinopharm Accord Of RMB322.1 Mln
Advisory: Incorrect alert on Sinopharm Group's 9-month revenue withdrawn
Brief: Sinopharm Group Says Resolved To Propose To Appoint Lian Wanyong As Executive Director
Brief: Sinopharm Group Posts H1 Net Income RMB 5,899.22 Mln
Brief: Sinopharm Says HY Net Profit Attributable RMB1.00 Bln For China National Medicines
Advisory: Incorrect net income alert on Sinopharm Group withdrawn
Advisory: Incorrect net income alert on Sinopharm Group withdrawn
Brief: Sinopharm Group Posts HY Revenue RMB37.79 Billion For Sinopharm Accord
Brief: Sinopharm Group Withdraws Resolution To Appointment PwC As International Auditor
Brief: BlackRock's Long Position On H-Shares Of Sinopharm Group Decreases To 5.76% On June 4
Brief: BPH Global Says Sources Bird's Nest Products From China National Pharmaceutical Group
China's Sinopharm drops most in over 8 months as quarterly profit falls
Brief: Sinopharm Group Says Qtrly Total Operating Revenue RMB147.27 Bln
Brief: Sinopharm To Propose Centralized Registration For Issue Of Debt Financing Instruments
Brief: Sinopharm Group Says China National Accord Medicine's Q1 Revenue RMB19,090 Mln